2. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911–30.
3. Drapkina O, Shepel R. Pleiotropic effects of vitamin D. Ration Pharmacother Cardiol 2016;12:227–32.
5. Holick MF. Vitamin D: evolutionary, physiological and health perspectives. Curr Drug Targets 2011;12:4–18.
6. Koundourakis NE, Margioris AN. Vitamin D and physical activity. Gowder SJTet al., editors. A critical evaluation of vitamin D - basic overview. London: InTechOpen. 2017;pp 3–46.
8. Shulhai AMA, Pavlyshyn HA, Shulhai OM. Peculiarities of the prevalence and risk factors for vitamin D deficiency in overweight and obese adolescents in Ukraine. Arch Balk Med Union 2019;54:57–63.
10. Hintzpeter B, Scheidt-Nave C, Muller MJ, Schenk L, Mensink GB. Higher prevalence of vitamin D deficiency is associated with immigrant background among children and adolescents in Germany. J Nutr 2008;138:1482–90.
13. Agudelo GM, Bedoya G, Estrada A, Patino FA, Munoz AM, Velasquez CM. Variations in the prevalence of metabolic syndrome in adolescents according to different criteria used for diagnosis: which definition should be chosen for this age group? Metab Syndr Relat Disord 2014;12:202–9.
14. Friend A, Craig L, Turner S. The prevalence of metabolic syndrome in children: a systematic review of the literature. Metab Syndr Relat Disord 2013;11:71–80.
16. Mottillo S, Filion KB, Genest J, Lawrence J, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010;56:1113–32.
18. Rho H, Lee S, Lee H, Shim K, Chun H, Byun A, et al. The association between serum vitamin D level and metabolic syndrome in elderly people: based on the Korean National Health and Nutrition Examination Survey 2012. Korean J Fam Pract 2016;6:315–21.
22. Pludowski P, Karczmarewicz E, Bayer M, Carter G, Chlebna-Sokol D, Czech-Kowalska J, et al. Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe - recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol 2013;64:319–27.
23. Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S, et al. The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes 2007;8:299–306.
25. Rafraf M, Hasanabad SK, Jafarabadi MA. Vitamin D status and its relationship with metabolic syndrome risk factors among adolescent girls in Boukan, Iran. Public Health Nutr 2014;17:803–9.
28. Pacifico L, Anania C, Osborn JF, Ferraro F, Bonci E, Olivero E, et al. Low 25(OH)D3 levels are associated with total adiposity, metabolic syndrome, and hypertension in Caucasian children and adolescents. Eur J Endocrinol 2011;165:603–11.
30. Pavlyshyn HA, Shulhai AMA. The association between vitamin D status and cardiometabolic disorders in overweight and obese adolescents. Ukr Biochem J 2021;93:72–81.
32. Vogt S, Baumert J, Peters A, Thorand B, Scragg R. Waist circumference modifies the association between serum 25(OH)D and systolic blood pressure: results from NHANES 2001-2006. J Hypertens 2016;34:637–45.
33. Verrusio W, Andreozzi P, Renzi A, Musumeci M, Gueli N, Cacciafesta M. Association between serum vitamin D and metabolic syndrome in middle-aged and older adults and role of supplementation therapy with vitamin D. Ann Ist Super Sanita 2017;53:54–9.
36. Dominguez E, Penafiel A, Pedrazaa A, Martínez Leo E. Molecular mechanisms from insulin-mimetic effect of vitamin D: treatment alternative in type 2 diabetes mellitus. Food Funct 2021;12:6682–90.
37. Kelishadi R, Farajzadegan Z, Bahreynian M. Association between vitamin D status and lipid profile in children and adolescents: a systematic review and meta-analysis. Int J Food Sci Nutr 2014;65:404–10.